​

Co-Diagnostics (CODX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CODX Stock Forecast

Co-Diagnostics (CODX) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $180.00, with a high of $180.00 and a low of $180.00. This represents a 10678.44% increase from the last price of $1.67.

- $40 $80 $120 $160 $200 High: $180 Avg: $180 Low: $180 Last Closed Price: $1.67

CODX Stock Rating

Co-Diagnostics stock's rating consensus is Hold, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (40.00%), 3 Hold (60.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 5 0 3 2 Strong Sell Sell Hold Buy Strong Buy

CODX Price Target Upside V Benchmarks

TypeNameUpside
StockCo-Diagnostics10678.44%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks31.62%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.67$1.67$1.67
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26--2--2
Mar, 26--2--2
Feb, 26--2--2
Jan, 261-1--2
Dec, 251-1--2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 14, 2022H.C. Wainwright$6.00$3.6564.38%259.28%
Aug 15, 2022H.C. Wainwright$9.00$4.48100.89%438.92%
May 16, 2022H.C. Wainwright$12.00$4.55163.74%618.56%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 26, 2025Maxim GroupHoldupgrade

Financial Forecast

EPS Forecast

$-40 $-24 $-8 $8 $24 $40 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$38.10$-13.57$-36.00$-37.20$-35.25--
Avg Forecast$1.10$0.09$-0.90$-1.22$-1.17$0.10$0.25
High Forecast$1.10$0.09$-0.90$-1.22$-1.17$0.10$0.25
Low Forecast$1.10$0.09$-0.90$-1.22$-1.17$0.10$0.25
Surprise %3363.64%-15177.78%3900.00%2949.18%2912.82%--

Revenue Forecast

$0 $20M $40M $60M $80M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$97.89M$34.22M$6.81M$3.92M$622.49K--
Avg Forecast$98.42M$38.32M$6.88M$4.14M$1.50M$77.63M$5.92M
High Forecast$98.42M$38.32M$6.88M$4.14M$1.50M$77.63M$5.92M
Low Forecast$98.42M$38.32M$6.88M$4.14M$1.50M$77.63M$5.92M
Surprise %-0.54%-10.70%-1.02%-5.45%-58.50%--

Net Income Forecast

$-50M $-32M $-14M $4M $22M $40M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$36.66M$-14.24M$-35.33M$-37.64M$-46.90M--
Avg Forecast$32.21M$2.64M$-26.41M$-35.80M$-34.34M$2.93M$7.34M
High Forecast$32.21M$2.64M$-26.41M$-35.80M$-34.34M$2.93M$7.34M
Low Forecast$32.21M$2.64M$-26.41M$-35.80M$-34.34M$2.93M$7.34M
Surprise %13.82%-639.08%33.78%5.13%36.58%--

CODX Forecast FAQ

Is Co-Diagnostics stock a buy?

Co-Diagnostics stock has a consensus rating of Hold, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Co-Diagnostics is a neutral investment for most analysts.

What is Co-Diagnostics's price target?

Co-Diagnostics's price target, set by 5 Wall Street analysts, averages $180 over the next 12 months. The price target range spans from $180 at the low end to $180 at the high end, suggesting a potential 10678.44% change from the previous closing price of $1.67.

How does Co-Diagnostics stock forecast compare to its benchmarks?

Co-Diagnostics's stock forecast shows a 10678.44% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (31.62%).

What is the breakdown of analyst ratings for Co-Diagnostics over the past three months?

  • April 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Co-Diagnostics’s EPS forecast?

Co-Diagnostics's average annual EPS forecast for its fiscal year ending in December 2026 is $0.1, marking a -100.28% decrease from the reported $-35.25 in 2025. Estimates for the following years are.

What is Co-Diagnostics’s revenue forecast?

Co-Diagnostics's average annual revenue forecast for its fiscal year ending in December 2026 is $77.63M, reflecting a 12371.22% increase from the reported $622.49K in 2025. The forecast for.

What is Co-Diagnostics’s net income forecast?

Co-Diagnostics's net income forecast for the fiscal year ending in December 2026 stands at $2.93M, representing a -106.26% decrease from the reported $-46.896M in 2025. Projections indicate .